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Purpose:  To  investigate  the  associations  between  gene  variants  in  cholesterol  24S-hydroxylase  (CYP46A1),  LIM
homeobox transcription factor 1-beta (LMX1B), plexin domain containing 2 (PLXDC2), toll-like receptor 4 (TLR4),
transmembrane and tetratricopeptide repeat containing 2 (TMTC2), zona pellucida glycoprotein 4 (ZP4), chromosome
2p16.3, and primary open-angle glaucoma (POAG).
Methods: We studied 462 POAG patients and 577 controls from three cohorts (Hong Kong, Shantou, and Beijing, China).
Twelve single-nucleotide polymorphisms (SNPs) were genotyped in the Hong Kong cohort using TaqMan genotyping
assay. Significant associations were validated in the Shantou and Beijing cohorts.
Results: Association of POAG with TLR4 rs7037117, in a recessive model, was identified in the Hong Kong and Shantou
cohorts (both southern Chinese, prec=0.0019) but not the Beijing cohort (northern Chinese). rs1533428 at chromosome
2p16.3 showed a consistent trend of age-specific association in all three cohorts. Genotypes TT + CT conferred a 2.16
fold of significantly increased risk to late-onset POAG (pdom=0.00025), but no significant risk to POAG of younger ages
of onset in the combined cohort. A joint effect was found between rs7037117 and rs1533428, with carriers of both higher-
risk genotypes having a 4.53 fold of increased disease risk (p=0.00028).
Conclusions: Our study reveals discrepant association patterns of 12 candidate SNPs in 7 genes/loci with POAG in
Chinese, provides positive replications for POAG markers rs1533428 at 2p16.3 and TLR4 rs7037117, and suggests that
rs1533428 is a putative risk variant for late-onset POAG. The identification of an age-specific association between
rs1533428 and late-onset POAG highlights a new genotype-phenotype association in POAG. Further studies are warranted
to confirm the age-specific association.
Glaucoma, a heterogenous group of degenerative optic
neuropathies [1], is the leading cause of irreversible blindness
worldwide [2,3]. Primary open-angle glaucoma (POAG) is a
common  form  of  glaucoma.  It  mainly  affects  the  elderly
population, with prevalence increasing with age [4]. Other
major risk factors include elevated intraocular pressure (IOP)
and genetic variations [5-7].
More than 20 POAG genetic loci have been mapped [6,
7] and 3 genes, myocilin [8], optineurin [9], and WD repeat
domain  36  [10],  identified.  Mutations  in  these  genes
altogether, however, account for less than 10% of POAG [6,
11-13]. In addition, more than 30 POAG-associated genes
have been reported [7]. Many of them, however, have failed
to be replicated across populations. Recently in a genome-
wide  association  study  (GWAS),  a  single-nucleotide
polymorphism (SNP) rs4236601 near the caveolin 1 (CAV1)
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and caveolin 2 (CAV2) genes was identified to be strongly
associated with POAG in the Icelandic population, and the
association  was  replicated  in  multiple  study  populations
including Chinese [14]. In another recent GWAS, SNPs at the
transmembrane  and  coiled-coil  domains  1  (TMCO1)  and
CDKN2B  antisense  RNA  1  (CDKN2B-AS1)  genes  were
found to be associated with POAG in different Caucasian
cohorts  [15].  Replication  is  essential  for  establishing  the
credibility of a genotype-phenotype association [16], and it
forms an important part of these GWAS [14,15].
Recently, significant associations of variants in the toll-
like receptor 4 (TLR4) [17], LIM homeobox transcription
factor 1-beta (LMX1B) [18], and cholesterol 24S-hydroxylase
(CYP46A1) [19] genes with POAG have been reported in
Japanese, British, and French populations, respectively. A
combined  case-control  and  linkage  study  revealed  strong
association of POAG with 2 SNPs at chromosomal region
2p16.3 in the Afro-Caribbean population of Barbados [20]. In
a GWAS report, 6 SNPs at 3 loci were associated with POAG
in  Japanese  [21].  However,  lack  of  association  had  been
reported for the SNPs at chromosome 2p16.3 [22-24], loci
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1629detected  in  the  Japanese  GWAS  [25],  and  recently  the
CYP46A1 [26] and TLR4 genes [27], whereas associations of
LMX1B  SNPs  with  POAG  have  not  been  replicated  in
populations other than the initial cohort. In this study, we
investigated associations of SNPs in these 7 loci with POAG
in  study  cohorts  from  three  cities  of  China:  Hong  Kong,
Shantou, and Beijing.
METHODS
Study participants: This study involved three cohorts of ethnic
Han  Chinese  in  different  parts  of  China:  a  Hong  Kong
(southern China) cohort recruited from the Hong Kong Eye
Hospital and the Prince of Wales Hospital, Hong Kong, and
a Shantou (southeast China) cohort from the Joint Shantou
International  Eye  Center,  Shantou.  The  Beijing  (northern
China) cohort was from the Tongren Eye Center, Beijing
[28].  Genetic  studies  were  approved  by  the  institutional
review  boards  of  all  collaborating  institutions  and  were
performed in accordance with the tenets of the Declaration of
Helsinki. Written informed consents were obtained from all
subjects before the studies.
Complete ocular examinations were performed for each
study  subject.  Diagnosis  of  POAG  were  based  on:  (1)
exclusion of secondary causes; (2) Shaffer grade III or IV open
iridocorneal  angle  on  gonioscopy;  and  (3)  glaucomatous
visual  field  change  detected  by  Humphrey  automated
perimeter with the glaucoma hemifield test. The IOP before
management,  measured  by  applanation  tonometry,  was
greater than 21 mmHg. The control subjects have no glaucoma
or  other  major  eye  diseases  except  mild  cataracts  and
refractive errors. They were recruited from elderly people
aged ≥60 years. Participants with known systemic diseases,
such as tumor, diabetes, cardiovascular diseases or neurologic
diseases, were excluded.
Candidate SNPs selection and genotyping: Recently reported
candidate SNPs around seven genes or loci were selected
based  on  their  strong  association  with  POAG:  SNP
rs7037117  in  TLR4  [17],  four  risk  SNPs
(rs944103,rs16929236,rs10733682,  and  rs867559),  a
protective SNP rs7854658 in LMX1B [18], and rs754203 in
CYP46A1  [19].  SNPs  rs1533428  and  rs12994401  at  the
chromosome 2p16.3 region were the most strongly associated
with  POAG  in  the  Barbados  [20],  so  were  SNPs
rs693421,rs7081455, and rs7961953 at locus 1q43, 10p12.31,
and 12q21.31, respectively, in a Japanese cohort [21].
Genomic DNA was extracted from whole blood using the
Qiamp Blood Kit (Qiagen, Hilden, Germany). All of the 12
candidate SNPs were genotyped in the Hong Kong cohort
using TaqMan® SNP genotyping assays (Applied Biosystems
[ABI], Foster City, CA) on an ABI prism 7000 Sequence
Detection System according to the supplier’s instructions.
SNPs that showed significant associations were genotyped in
the Shantou and Beijing cohorts.
Statistical analyses: The PLINK program (version 1.07) [29]
was used for association analyses unless otherwise stated.
Hardy–Weinberg equilibrium (HWE) was assessed for each
SNP by χ2 test. Allelic, genotypic and model-based (dominant
and recessive) associations of the SNPs with POAG were
analyzed by χ2 test. Because of gender imbalance across our
sample sets, we adjusted gender in association analysis using
logistic  regression.  As  gender  adjustment  did  not  show
appreciable  effects  on  the  respective  associations,  only
unadjusted  odds  ratios  (ORs)  were  presented.  Gene-wise
linkage disequilibrium (LD) between SNPs and haplotype
frequencies  were  tested  for  disease  association  using
Haploview. For gene-gene interactions, pairwise SNP×SNP
interactions were assessed using the epistasis algorithm in
PLINK. In parallel, two- and high-order interactions were
analyzed  using  the  multifactor  dimensionality  reduction
(MDR) software [30] (version 1.1.0). Data from different
cohorts  or  studies  were  pooled  using  a  Mantel-Haenszel
model with fixed or random effect in the Review Manager
software  (version  5.0.24;  the  Cochrane  Collaboration,
Copenhagen, Denmark). In this study, SNPs giving p-values
<0.05 were considered a possible association and included in
replication analyses. To conclude the association, we used the
Bonferroni method to correct the p-values for multiple testing,
using a stringent threshold. First, for correcting p-values in
model-based analysis, including allele, full model, dominant
and recessive models, a p-value of <0.0010 (0.05÷12÷4) was
considered statistically significant. Second, for correcting p-
values  in  stratification  analysis,  a  p-value  of  <0.00034
(0.05÷12÷4÷3) was considered statistically significant.
RESULTS
Characteristics  of  study  subjects:  A  total  of  462  POAG
patients and 577 controls were studied: 184 patients and 230
controls from Hong Kong, 102 patients and 147 controls from
Shantou,  and  176  patients  and  200  controls  from  Beijing
(Table  1).  For  POAG,  the  age  of  disease  onset  may  be
unreliable  because  of  the  absence  or  unawareness  of
symptoms at early stages. We resorted, as a surrogate, to use
the age at diagnosis (AAD), which was defined as the age at
which initial diagnosis of glaucoma was made. All patients in
this study have records of no obvious vision impairment at
least  a  year  before  diagnosis.  The  ranges  of  AAD  and
maximum  IOP  were  large  since  we  did  not  confine
recruitment of study subjects in a narrower range. In contrast,
since we included healthy subjects aged ≥60 years as controls,
the  mean  age  in  the  control  group  of  each  cohort  was
significantly greater than in respective patient group (p<0.05,
student’s t-test). The proportions of gender were significantly
different between the case and control groups in the Hong
Kong and Shantou cohorts (p<0.05, χ2 test), we therefore
adjusted gender in association analyses, where applicable,
using logistic regression.
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1630Association of individual SNP with POAG: All the 12 SNPs
in the Hong Kong cohort conformed to HWE in controls. In
allelic association analyses, only LMX1B rs944103 showed a
mild association (p=0.035; Table 2) which did not withstand
Bonferroni  correction,  corrected  p-value
(pcorr)=0.035×12=0.42.  TLR4  rs7037117  was  marginally
associated with glaucoma in a full model (p=0.049), and it
showed a trend toward increased-risk of POAG in a recessive
model  (prec=0.063,  ORrec=2.29,  95%  CI:  0.94–5.57;  after
adjustment  for  gender,  padj=0.053).  SNP  rs1533428  at
chromosome 2p16.3 also gave a marginal p-value in the full
model (p=0.088). It indicated possible association with POAG
in a dominant model (pdom=0.030, ORdom=1.58, 95% CI: 1.04–
2.38; padj=0.015; Table 3). The other 9 SNPs did not show
association with POAG.
We  classified  the  patients  with  AAD  <35  years  as
juvenile-onset POAG, between 35 and 60 years as adult-onset
POAG,  and  >60  years  as  late-onset  POAG.  Association
analyses by comparing each stratum of patients with overall
controls showed that genotypes TT + CT of chromosome
2p16.3 rs1533428 conferred a significant increased-risk to
late-onset POAG (pdom=0.00058, ORdom=2.53, 95% CI: 1.48–
4.34) but not to juvenile- or adult-onset POAG (Table 3).
However, the p-value was at borderline when multiple testing
was taken into account (p>0.00034). The other 11 SNPs did
not show such a stratified-age association.
TLR4  rs7037117  showed  a  possible  association  with
POAG in a recessive model in the Shantou cohort. The GG
genotype, present in 14.7% of patients and 4.8% controls,
conferred a 3.45 fold of increased risk to POAG (95% CI:
1.35–8.79, prec=0.0066, padj=0.0076). In the combined Hong
Kong  and  Shantou  southern  subjects,  the  association  was
enhanced  (prec=0.0019,  ORrec=2.78,  95%  CI:  1.46–5.30),
although did not reach the significance threshold (p>0.0010).
In  the  Beijing  cohort,  however,  the  association  between
rs7037117 and POAG was insignificant (GG genotype 5.7%
in POAG versus 6.0% in controls; prec=0.90; Figure 1).
The  higher-risk  genotypes  of  rs1533428,  TT  +  CT,
showed a trend toward an increased-risk of POAG in the
Shantou cohort (pdom=0.074, ORdom=1.62, 95% CI: 0.95–2.77;
Table 3). The ORs of the risk genotypes also increased with
ascending AAD of POAG (Table 3), consistent with the Hong
Kong cohort. In the Beijing cohort, the genotype distributions
of rs1533428 in patients and controls and the pattern of the
stratified-age association were similar to those in the Hong
Kong  and  Shantou  cohorts.  However,  no  statistical
significance  was  reached  in  individual  replication  cohorts
(Table 3). When study subjects were combined in these two
cohorts, rs1533428 showed a possible association with POAG
(pdom=0.042;  ORdom=1.40,  95%  CI:  1.01–1.94).  When
stratified by AAD, the risk genotypes had an odds ratio of
1.15, 1.56 and 1.71 for early-onset, adult-onset and late-onset
POAG,  respectively,  indicating  an  ascending  trend  as
observed in the Hong Kong cohort. In the combined subjects
from all three cohorts, an enhanced association with POAG
was obtained (pdom=0.0033, pcorr=0.036; ORdom=1.47, 95% CI:
1.14–1.90). The higher-risk genotypes TT + CT conferred a
2.16  fold  of  increased-risk  toward  late-onset  POAG
(pdom=0.00025).  The  association  withstood  stringent
Bonferroni  correction  (p<0.00034),  yet  imposed  mild  but
insignificant risk upon juvenile- (pdom=0.59, ORdom=1.12) or
adult-onset POAG (pdom=0.15, ORdom=1.29). The TT and CT
genotypes individually conferred similar risk to late-onset
POAG as each compared to the CC genotype (data not shown),
supporting a dominant effect.
Linkage  disequilibrium  and  haplotype-based  association:
Linkage  disequilibrium  between  SNPs  rs1533428  and
rs12994401 at chromosome 2p16.3 was weak in the Hong
Kong  cohort  (D’=0.096  and  0.30  in  POAG  and  controls
respectively; r2=0.007 and 0.075, respectively). Genotyping
rs12994401 in the Shantou cohort revealed weak LD among
patients  (D’=0.23,  r2=0.037)  and  controls  (D’=0.25,
r2=0.053).  A  common  haplotype  (C-C)  defined  by  the
wildtype  alleles  conferred  a  significantly  reduced  risk  of
TABLE 1. DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF THE STUDY SUBJECTS.
     
Age at diagnosis years) † Highest recorded IOP (mmHg)
Group Sample size Female (%) * Range Mean (SD) Range Mean (SD)
Hong Kong cohort
POAG 184 64 (34.8) 11–88 59.7 (16.6) 22–69 31.0 (9.4)
Control 230 124 (53.9) 60–94 73.5 (7.5) 6–20 13.5 (3.0)
Shantou cohort
POAG 102 20 (20.0) 11–85 45.2 (20.8) 22.5–58 36.5 (9.6)
Control 147 94 (63.9) 63–96 74.0 (6.4) 7–21 12.7 (2.9)
Beijing cohort
POAG 176 38 (21.6) 10–82 38.9 (16.3) 22–70 36.8 (11.0)
Control 200 50 (25.0) 61–85 69.4 (6.0) 10–21 13.0 (3.0)
        *There was gender imbalance across our sample sets. We adjusted gender in association analysis using logistic regression and
        found the adjustment did not affect the associations. †For the controls, age at diagnosis refers to the age at study enrolment. SD:
        standard deviation; IOP: intraocular pressure.
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1633POAG in the Hong Kong cohort (p=0.030, OR=0.74, 95% CI:
0.56–0.97) but not in the Shantou cohort (p=0.32). However,
the association in the Hong Kong cohort could not withstand
permutation correction (pperm=0.07). No haplotype defined by
the LMX1B SNPs showed a significant association.
Joint effect of SNPs: Pairwise SNP×SNP interaction analysis
in PLINK and two-locus and higher-order interaction analyses
in MDR did not reveal statistically significant interactions.
Combination of both higher-risk genotypes at rs1533428 and
rs7037117 conferred a greater risk to POAG than single risk
genotype, indicating an additive effect (Table 4). In particular,
in  the  combined  cohort  carriers  with  both  higher-risk
genotypes had a strong increased-risk of POAG (ORjoint=4.53;
p=0.00028).
DISCUSSION
In this investigation of 12 candidate SNPs, association with
POAG was found for TLR4 rs7037117 (Prec=0.0019), which
was initially identified in a Japanese population [17], in the
Hong Kong and Shantou cohorts of southern Chinese, but not
in the Beijing cohort of northern Chinese. In a recent study,
no association was found between rs7037117 and normal
tension glaucoma in a Korean population [27]. These findings
suggest a geographic diversity in the association. Moreover,
while  rs7037117  was  associated  with  normal  tension
glaucoma in Japanese [17], our results suggest that TLR4 may
also be implicated in high-tension POAG. Such geographic
and phenotypic diversities might have resulted from other yet-
to-identify  genetic  and/or  environmental  factors.  SNP
rs1533428 at chromosome 2p16.3 showed similar trends of
association  with  POAG  in  all  our  three  Chinese  cohorts,
although a significant p-value (p<0.05) was only detected in
the Hong Kong cohort. Moreover, combined analysis of the
discovery  and  replication  cohorts,  a  common  practice  in
genetic  association  studies  [14,15],  had  led  to  a  more
significant  P-value,  indicating  a  positive  replication.
Furthermore,  rs1533428  and  rs7037117  together  had  an
additive effect, supporting the polygenic property of POAG.
Except for these two, we did not find significant association
between POAG and other candidate SNPs at or around the
CYP46A1, LMX1B, PLXDC2, TMTC2, and ZP4 genes. Our
findings exemplify the ethnic diversities in POAG genetics
and the importance of replication analysis for new candidate
genes of POAG.
Ethnic  heterogeneity  exists  in  the  associations  of
rs1533428  and  rs12994401  at  chromosome  2p16.3  with
POAG  (between-study  variance  Tau-square=0.10,
p<0.00001; Figure 2). In the Afro-Caribbean population of
Barbados,  these  two  SNPs  are  strongly  associated  with
POAG,  with  rs12994401  [T]  (ORhom>33.0)  conferring  a
stronger risk than rs1533428 [T] (ORhom>5.5). They are in
strong  LD  (D’=0.72)  [20].  In  contrast,  in  the  African-
American  and  Ghanaian  populations  rs12994401  [T]
conferred a reduced-risk of POAG (OR=0.53, p=0.003) in the
African-American population but a trend of increased-risk
(OR=1.6,  p=0.22)  in  the  Ghanaian  population.  However,
rs1533428 [T] conferred a mild but nonsignificant risk to
POAG (OR≥1.05, p>0.10) in both populations. These two
SNPs were in weak LD in either population [22]. In contrast
to the African populations, we found that rs12994401 [T] was
not significantly associated with POAG in Chinese, whereas
rs1533428  [T],  mainly  in  a  dominant  model,  conferred  a
significantly increased risk, and there is low LD between
them.  In  a  Japanese  population,  rs12994401  [T]  and
rs1533428 [T] have a very mild trend toward an increased risk
of POAG (OR≥1.02), although no significance was reached.
Notably, after adjusting for age, gender, IOP and refractive
error, rs1533428 [T] remained a trend of increased-POAG risk
(OR=1.05),  whereas  rs12994401  [T]  showed  a  reverse
tendency (OR=0.93) [23]. Recently in a Korean cohort, both
the  rs1533428  [T]  and  rs12994401  [T]  showed  a  lack  of
association, and the odds ratios were to a reversed direction
[24]. In view of such discrepancies, we conducted a meta-
analysis of all reported studies on these two SNPs, involving
over 1,600 POAG and 2,000 controls (Figure 2). rs1533428
[T] showed a same trend of increased POAG-risk across all
study populations except Korean, giving a combined p-value
of 0.035. In contrast, rs12994401 showed an insignificant
association (Pmeta=0.067). These findings together suggest that
rs1533428 is more likely to be a risk marker for POAG at
Figure 1. Association of TLR4 rs7037117 with POAG in the recessive model. Squares indicate cohort-specific odds ratio (OR); the size of
the box is proportional to the weight of the study cohort; horizontal lines indicate 95% confidence interval (CI); diamond indicates summary
OR with its corresponding 95% CI. Meta-analysis indicates a significant association between rs7037117 and POAG.
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1635chromosome  2p16.3,  but  with  high  degree  of  ethnic
diversities.
Linkage of the chromosome 2p locus in 5 families with
autosomal dominant POAG had been reported [20]. Also,
genetic linkage between the chromosome 2p15–16 region
with autosomal dominant POAG has been identified in six
white  and  one  Afro-Caribbean  families  [31],  and  in  two
Chinese families [32]. Thus, the chromosome 2p16 region
may harbor one or more disease genes for POAG. However,
no  functional  gene  at  chromosome  2p16.3  surrounding
rs1533428 has been annotated except for a hypothetical gene
LOC730100, which encodes a predicted protein with some
homology  to  the  TRF1-interacting  ankyrin-related  ADP-
ribose  polymerase.  The  latter  plays  a  regulatory  role  in
telomere length [20,33], which is associated with cellular
senescence and apoptosis [34].
We have identified a stratified-age association between
POAG and rs1533428, where the TT and CT genotypes were
significantly associated with late-onset POAG but not adult-
or  juvenile-onset  POAG.  We  obtained  consistent  findings
across three cohorts from different geographical locations in
China, indicating no artifact of a cohort effect. Also, as all our
study subjects have no known systemic diseases, such age-
specific pattern was unlikely attributed to interactions with
other age-related morbid conditions. Thus, rs1533428 is likely
a  susceptibility  genetic  marker  for  late-onset  POAG  in
Chinese. The higher-risk genotypes conferred a 2.16 fold of
increased  risk  to  late-onset  POAG  in  a  dominant  model,
similar to the dominant OR in the study of Jiao et al. [20]
(ORdom=2.48 in the combined group), whose patients were
mainly late onset (mean age >70 years) [20]. It is therefore
evident  that  rs1533428  correlates  with  late-onset  POAG.
Interestingly, however, in a Korean study population, the SNP
was not associated with POAG in patients aged above 62.5
years [24]. This further highlights the ethnic diversities in this
association and the possibility of other modifying genetic and
environmental risk factors.
Similar age-specific genetic correlation had been found
in  glaucoma  and  other  diseases.  For  example,  myocilin
glaucoma is frequently diagnosed between 20 and 40 years of
Figure 2. Allelic association of SNPs rs1533428 [T] and rs12994401 [T] at 2p16.3 with POAG. Squares indicate cohort-specific odds ratio
(OR); the size of the box is proportional to the weight of the study population; horizontal lines indicate 95% confidence interval (CI); diamond
indicates summary OR with its corresponding 95% CI. Meta-analysis indicates significant associations of rs1533428 (p=0.03), but not
rs12994401 (p=0.07), with POAG.
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1636age  [35].  Allingham  et  al.  [36]  established  a  linkage  to
chromosome 15q11–13 in families with early-onset POAG.
SNP  rs4293393  in  the  uromodulin  (UMOD)  gene  was
strongly associated with chronic kidney disease in patients
aged  above  70  [37].  deleted  in  malignant  brain  tumors
1 (DMBT1) SNPs rs2981745 and rs11523871 significantly
increased breast cancer risk only in women aged above 60
years  [38].  The  biologic  relevance  of  the  stratified-age
association found in our POAG patients is not known. Late-
onset POAG is more likely to follow the common disease
common variant mechanism, whereas juvenile-onset POAG
may be caused by gene mutations with high penetrance [8].
Hence, it is possible that certain common polymorphisms,
e.g., rs1533428, act predominantly on late-onset POAG. Since
penetrance of susceptibility polymorphisms are usually low,
other risk factors are needed to determine the development of
disease, such as an older age [1,5]. Therefore the age-specific
association  may  suggest  an  age-dependent  penetrance  of
rs1533428 in the development of POAG.
This study is a direct association investigation between
patients and controls. However, we included only a limited
number of candidate SNPs from each gene/locus. A more
exhaustive  investigation,  e.g.,  haplotype-tagging  SNP
analysis, could provide additional useful genetic information.
Also, the sample size in each stratum was not large, thus
limiting  the  statistical  power  to  detect  significance  in
individual cohorts. Furthermore, this study is a replication and
the stratification analysis by age was retrospective, which is
suboptimal for testing new associations. Therefore further
prospective discovery studies specifically aiming at testing
the age-specific association between rs1533428 and POAG
are warranted.
In summary, we have identified discrepant association
patterns of 12 candidate SNPs in 7 genes/loci with POAG in
the Chinese population, exemplifying ethnic diversities of
those  associations  and  the  need  of  replications  in  genetic
studies.  We  have,  for  the  first  time,  provided  positive
replications for SNPs rs1533428 at chromosome 2p16.3 and
TLR4 rs7037117 in Chinese and detected an additive effect
between  them.  The  identification  of  an  age-specific
association between rs1533428 and late-onset POAG may
highlight a new genotype-phenotype association in POAG.
ACKNOWLEDGMENTS
We express our greatest gratitude to all participants in this
study. The work in this paper was supported in part by the
Endowment Fund for Lim Por-Yen Eye Genetics Research
Centre, Hong Kong, and research grant 2140597 from the
General Research Fund, Hong Kong.
REFERENCES
1. Kwon YH, Fingert JH, Kuehn MH, Alward WL. Primary open-
angle glaucoma. N Engl J Med 2009; 360:1113-24. [PMID:
19279343]
2. Quigley HA, Broman AT. The number of people with glaucoma
worldwide  in  2010  and  2020.  Br  J  Ophthalmol  2006;
90:262-7. [PMID: 16488940]
3. Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram
R,  Pokharel  GP,  Mariotti  SP.  Global  data  on  visual
impairment in the year 2002. Bull World Health Organ 2004;
82:844-51. [PMID: 15640920]
4. Quigley HA. Number of people with glaucoma worldwide. Br
J Ophthalmol 1996; 80:389-93. [PMID: 8695555]
5. Rudnicka  AR,  Mt-Isa  S,  Owen  CG,  Cook  DG,  Ashby  D.
Variations in primary open-angle glaucoma prevalence by
age,  gender,  and  race:  a  Bayesian  meta-analysis.  Invest
Ophthalmol Vis Sci 2006; 47:4254-61. [PMID: 17003413]
6. Fan BJ, Wang DY, Lam DS, Pang CP. Gene mapping for
primary  open  angle  glaucoma.  Clin  Biochem  2006;
39:249-58. [PMID: 16332362]
7. Allingham RR, Liu Y, Rhee DJ. The genetics of primary open-
angle glaucoma: a review. Exp Eye Res 2009; 88:837-44.
[PMID: 19061886]
8. Stone EM, Fingert JH, Alward WL, Nguyen TD, Polansky JR,
Sunden SL, Nishimura D, Clark AF, Nystuen A, Nichols BE,
Mackey DA, Ritch R, Kalenak JW, Craven ER, Sheffield VC.
Identification  of  a  gene  that  causes  primary  open  angle
glaucoma. Science 1997; 275:668-70. [PMID: 9005853]
9. Rezaie T, Child A, Hitchings R, Brice G, Miller L, Coca-Prados
M,  Heon  E,  Krupin  T,  Ritch  R,  Kreutzer  D,  Crick  RP,
Sarfarazi  M.  Adult-onset  primary  open-angle  glaucoma
caused  by  mutations  in  optineurin.  Science  2002;
295:1077-9. [PMID: 11834836]
10. Monemi S, Spaeth G, DaSilva A, Popinchalk S, Ilitchev E,
Liebmann J, Ritch R, Heon E, Crick RP, Child A, Sarfarazi
M. Identification of a novel adult-onset primary open-angle
glaucoma (POAG) gene on 5q22.1. Hum Mol Genet 2005;
14:725-33. [PMID: 15677485]
11. Fan BJ, Wang DY, Cheng CY, Ko WC, Lam SC, Pang CP.
Different WDR36 mutation pattern in Chinese patients with
primary  open-angle  glaucoma.  Mol  Vis  2009;  15:646-53.
[PMID: 19347049]
12. Fan BJ, Wang DY, Fan DS, Tam PO, Lam DS, Tham CC, Lam
CY, Lau TC, Pang CP. SNPs and interaction analyses of
myocilin, optineurin, and apolipoprotein E in primary open
angle glaucoma patients. Mol Vis 2005; 11:625-31. [PMID:
16148883]
13. Leung YF, Fan BJ, Lam DS, Lee WS, Tam PO, Chua JK, Tham
CC, Lai JS, Fan DS, Pang CP. Different optineurin mutation
pattern in primary open-angle glaucoma. Invest Ophthalmol
Vis Sci 2003; 44:3880-4. [PMID: 12939304]
14. Thorleifsson G, Walters GB, Hewitt AW, Masson G, Helgason
A, DeWan A, Sigurdsson A, Jonasdottir A, Gudjonsson SA,
Magnusson  KP,  Stefansson  H,  Lam  DS,  Tam  PO,
Gudmundsdottir GJ, Southgate L, Burdon KP, Gottfredsdottir
MS, Aldred MA, Mitchell P, St Clair D, Collier DA, Tang N,
Sveinsson O, Macgregor S, Martin NG, Cree AJ, Gibson J,
Macleod  A,  Jacob  A,  Ennis  S,  Young  TL,  Chan  JC,
Karwatowski WS, Hammond CJ, Thordarson K, Zhang M,
Wadelius C, Lotery AJ, Trembath RC, Pang CP, Hoh J, Craig
JE, Kong A, Mackey DA, Jonasson F, Thorsteinsdottir U,
Stefansson K. Common variants near CAV1 and CAV2 are
associated  with  primary  open-angle  glaucoma.  Nat  Genet
2010; 42:906-9. [PMID: 20835238]
Molecular Vision 2012; 18:1629-1639 <http://www.molvis.org/molvis/v18/a168> © 2012 Molecular Vision
163715. Burdon KP, Macgregor S, Hewitt AW, Sharma S, Chidlow G,
Mills RA, Danoy P, Casson R, Viswanathan AC, Liu JZ,
Landers J, Henders AK, Wood J, Souzeau E, Crawford A, Leo
P,  Wang  JJ,  Rochtchina  E,  Nyholt  DR,  Martin  NG,
Montgomery  GW,  Mitchell  P,  Brown  MA,  Mackey  DA,
Craig  JE.  Genome-wide  association  study  identifies
susceptibility loci for open angle glaucoma at TMCO1 and
CDKN2B–AS1.  Nat  Genet  2011;  43:574-8.  [PMID:
21532571]
16. Chanock SJ, Manolio T, Boehnke M, Boerwinkle E, Hunter DJ,
Thomas G, Hirschhorn JN, Abecasis G, Altshuler D, Bailey-
Wilson JE, Brooks LD, Cardon LR, Daly M, Donnelly P,
Fraumeni  JF  Jr,  Freimer  NB,  Gerhard  DS,  Gunter  C,
Guttmacher AE, Guyer MS, Harris EL, Hoh J, Hoover R,
Kong CA, Merikangas KR, Morton CC, Palmer LJ, Phimister
EG, Rice JP, Roberts J, Rotimi C, Tucker MA, Vogan KJ,
Wacholder  S,  Wijsman  EM,  Winn  DM,  Collins  FS.
Replicating genotype-phenotype associations. Nature 2007;
447:655-60. [PMID: 17554299]
17. Shibuya E, Meguro A, Ota M, Kashiwagi K, Mabuchi F, Iijima
H, Kawase K, Yamamoto T, Nakamura M, Negi A, Sagara T,
Nishida  T,  Inatani  M,  Tanihara  H,  Aihara  M,  Araie  M,
Fukuchi T, Abe H, Higashide T, Sugiyama K, Kanamoto T,
Kiuchi Y, Iwase A, Ohno S, Inoko H, Mizuki N. Association
of  Toll-like  receptor  4  gene  polymorphisms  with  normal
tension  glaucoma.  Invest  Ophthalmol  Vis  Sci  2008;
49:4453-7. [PMID: 18586872]
18. Park S, Jamshidi Y, Vaideanu D, Bitner-Glindzicz M, Fraser S,
Sowden JC. Genetic risk for primary open-angle glaucoma
determined by LMX1B haplotypes. Invest Ophthalmol Vis
Sci 2009; 50:1522-30. [PMID: 18952915]
19. Fourgeux C, Martine L, Bjorkhem I, Diczfalusy U, Joffre C,
Acar N, Creuzot-Garcher C, Bron A, Bretillon L. Primary
open-angle  glaucoma:  association  with  cholesterol  24S-
hydroxylase (CYP46A1) gene polymorphism and plasma 24-
hydroxycholesterol levels. Invest Ophthalmol Vis Sci 2009;
50:5712-7. [PMID: 19553612]
20. Jiao X, Yang Z, Yang X, Chen Y, Tong Z, Zhao C, Zeng J, Chen
H, Gibbs D, Sun X, Li B, Wakins WS, Meyer C, Wang X,
Kasuga D, Bedell M, Pearson E, Weinreb RN, Leske MC,
Hennis  A,  DeWan  A,  Nemesure  B,  Jorde  LB,  Hoh  J,
Hejtmancik JF, Zhang K. Common variants on chromosome
2  and  risk  of  primary  open-angle  glaucoma  in  the  Afro-
Caribbean population of Barbados. Proc Natl Acad Sci USA
2009; 106:17105-10. [PMID: 19805132]
21. Nakano M, Ikeda Y, Taniguchi T, Yagi T, Fuwa M, Omi N,
Tokuda Y, Tanaka M, Yoshii K, Kageyama M, Naruse S,
Matsuda  A,  Mori  K,  Kinoshita  S,  Tashiro  K.  Three
susceptible  loci  associated  with  primary  open-angle
glaucoma identified by genome-wide association study in a
Japanese  population.  Proc  Natl  Acad  Sci  USA  2009;
106:12838-42. [PMID: 19625618]
22. Liu  Y,  Qin  X,  Schmidt  S,  Allingham  RR,  Hauser  MA.
Association  between  chromosome  2p16.3  variants  and
glaucoma in populations of African descent. Proc Natl Acad
Sci USA. 2010 [PMID: 20382863]
23. Mabuchi F, Sakurada Y, Kashiwagi K, Yamagata Z, Lijima H,
Tsukahara S. Lack of association of common variants on
chromosome 2p with primary open-angle glaucoma in the
Japanese  population.  Proc  Natl  Acad  Sci  USA  2010;
107:E90-1. [PMID: 20424111]
24. Kim K, Yun YJ, Kim S, Kim JS, Kim CS, Kang C. Analysis of
an extended chromosome locus 2p14–21 for replication of the
2p16.3 association with glaucoma susceptibility. Mol Vis
2011; 17:1136-43. [PMID: 21552472]
25. Rao KN, Kaur I, Chakrabarti S. Lack of association of three
primary open-angle glaucoma-susceptible loci with primary
glaucomas in an Indian population. Proc Natl Acad Sci USA
2009; 106:E125-6. [PMID: 19846772]
26. Mossböck G, Weger M, Faschinger C, Schmut O, Renner W,
Wedrich  A,  Zimmermann  C,  El-Shabrawi  Y.  Role  of
cholesterol 24S-hydroxylase gene polymorphism (rs754203)
in primary open angle glaucoma. Mol Vis 2011; 17:616-20.
[PMID: 21386929]
27. Suh  W,  Kim  S,  Ki  CS,  Kee  C.  Toll-like  Receptor  4  gene
polymorphisms  do  not  associate  with  normal  tension
glaucoma  in  a  Korean  population.  Mol  Vis  2011;
17:2343-8. [PMID: 21921986]
28. Jia LY, Tam PO, Chiang SW, Ding N, Chen LJ, Yam GH, Pang
CP,  Wang  NL.  Multiple  gene  polymorphisms  analysis
revealed  a  different  profile  of  genetic  polymorphisms  of
primary open-angle glaucoma in northern Chinese. Mol Vis
2009; 15:89-98. [PMID: 19145250]
29. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA,
Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham
PC. PLINK: a tool set for whole-genome association and
population-based linkage analyses. Am J Hum Genet 2007;
81:559-75. [PMID: 17701901]
30. Ritchie MD, Hahn LW, Roodi N, Bailey LR, Dupont WD, Parl
FF, Moore JH. Multifactor-dimensionality reduction reveals
high-order interactions among estrogen-metabolism genes in
sporadic breast cancer. Am J Hum Genet 2001; 69:138-47.
[PMID: 11404819]
31. Suriyapperuma SP, Child A, Desai T, Brice G, Kerr A, Crick
RP,  Sarfarazi  M.  A  new  locus  (GLC1H)  for  adult-onset
primary open-angle glaucoma maps to the 2p15-p16 region.
Arch Ophthalmol 2007; 125:86-92. [PMID: 17210857]
32. Lin Y, Liu T, Li J, Yang J, Du Q, Wang J, Yang Y, Liu X, Fan
Y, Lu F, Chen Y, Pu Y, Zhang K, He X, Yang Z. A genome-
wide scan maps a novel autosomal dominant juvenile-onset
open-angle  glaucoma  locus  to  2p15–16.  Mol  Vis  2008;
14:739-44. [PMID: 18432317]
33. Donigian JR, de Lange T. The role of the poly(ADP-ribose)
polymerase  tankyrase1  in  telomere  length  control  by  the
TRF1 component of the shelterin complex. J Biol Chem 2007;
282:22662-7. [PMID: 17561506]
34. Rodriguez-Brenes  IA,  Peskin  CS.  Quantitative  theory  of
telomere length regulation and cellular senescence. Proc Natl
Acad Sci USA 2010; 107:5387-92. [PMID: 20207949]
35. Alward WL, Fingert JH, Coote MA, Johnson AT, Lerner SF,
Junqua D, Durcan FJ, McCartney PJ, Mackey DA, Sheffield
VC, Stone EM. Clinical features associated with mutations in
the chromosome 1 open-angle glaucoma gene (GLC1A). N
Engl J Med 1998; 338:1022-7. [PMID: 9535666]
36. Allingham RR, Wiggs JL, Hauser ER, Larocque-Abramson
KR, Santiago-Turla C, Broomer B, Del Bono EA, Graham
FL, Haines JL, Pericak-Vance MA, Hauser MA. Early adult-
onset  POAG  linked  to  15q11–13  using  ordered  subset
Molecular Vision 2012; 18:1629-1639 <http://www.molvis.org/molvis/v18/a168> © 2012 Molecular Vision
1638analysis. Invest Ophthalmol Vis Sci 2005; 46:2002-5. [PMID:
15914615]
37. Gudbjartsson DF, Holm H, Indridason OS, Thorleifsson G,
Edvardsson V, Sulem P, de Vegt F, d'Ancona FC, den Heijer
M,  Wetzels  JF,  Franzson  L,  Rafnar  T,  Kristjansson  K,
Bjornsdottir  US,  Eyjolfsson  GI,  Kiemeney  LA,  Kong  A,
Palsson R, Thorsteinsdottir U, Stefansson K. Association of
variants at UMOD with chronic kidney disease and kidney
stones-role of age and comorbid diseases. PLoS Genet 2010;
6:e1001039. [PMID: 20686651]
38. Tchatchou  S,  Riedel  A,  Lyer  S,  Schmutzhard  J,  Strobel-
Freidekind  O,  Gronert-Sum  S,  Mietag  C,  D'Amato  M,
Schlehe B, Hemminki K, Sutter C, Ditsch N, Blackburn A,
Hill  LZ,  Jerry  DJ,  Bugert  P,  Weber  BH,  Niederacher  D,
Arnold N, Varon-Mateeva R, Wappenschmidt B, Schmutzler
RK,  Engel  C,  Meindl  A,  Bartram  CR,  Mollenhauer  J,
Burwinkel  B.  Identification  of  a  DMBT1  polymorphism
associated with increased breast cancer risk and decreased
promoter  activity.  Hum  Mutat  2010;  31:60-6.  [PMID:
19830809]
Molecular Vision 2012; 18:1629-1639 <http://www.molvis.org/molvis/v18/a168> © 2012 Molecular Vision
Articles are provided courtesy of Emory University and the Zhongshan Ophthalmic Center, Sun Yat-sen University, P.R. China.
The print version of this article was created on 14 June 2012. This reflects all typographical corrections and errata to the article
through that date. Details of any changes may be found in the online version of the article.
1639